A new UCLA study has found that artificial intelligence could help doctors identify prostate cancer patients most ...

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto have revealed how a tiny ...

Patients then receive the therapeutic component of Pluvicto, which attaches to the cancer cells via the same antigen target and emits radiation to kill their DNA. UCLA Health’s Outpatient ...

UCLA co-led study is first trial analyzing a targeted therapy drug specifically made for brain tumors. In an international study co-led by UCLA Health Jonsson Comprehensive Cancer Center ...

breaking this tolerance and causing the body to instead attack the cancer," said corresponding author André Nel, a UCLA distinguished professor of medicine at the David Geffen School of Medicine ...

A new artificial intelligence tool could help doctors determine which prostate cancer patients are most likely to benefit ...